当前位置:首页 - 行情中心 - 津药药业(600488) - 财务分析 - 现金流量表

津药药业

(600488)

  

流通市值:62.24亿  总市值:62.24亿
流通股本:10.92亿   总股本:10.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金574,418,388.842,402,733,620.551,798,274,725.191,218,663,367.77
  收到的税费返还3,532,630.16103,877,162.4689,352,421.9253,204,040.81
  收到其他与经营活动有关的现金6,751,690.1967,838,698.3343,372,316.526,218,774.87
  经营活动现金流入小计584,702,709.192,574,449,481.341,930,999,463.611,298,086,183.45
  购买商品、接受劳务支付的现金309,062,320.931,348,889,986.881,073,145,869.5692,847,075.55
  支付给职工以及为职工支付的现金190,270,934.78587,244,926.79448,904,874.83325,753,338.18
  支付的各项税费61,668,237.27233,805,562.21167,782,011.33101,416,404.64
  支付其他与经营活动有关的现金35,053,517.82268,029,342.5207,779,046.99157,868,786.06
  经营活动现金流出小计596,055,010.82,437,969,818.381,897,611,802.651,277,885,604.43
  经营活动产生的现金流量净额-11,352,301.61136,479,662.9633,387,660.9620,200,579.02
二、投资活动产生的现金流量:
  收回投资收到的现金-8,182,019--
  取得投资收益收到的现金-1,685,119.851,685,119.851,685,119.85
  处置固定资产、无形资产和其他长期资产收回的现金净额13,5007,790,0006,800,0000
  收到的其他与投资活动有关的现金-109,692,000--
  投资活动现金流入小计13,500127,349,138.858,485,119.851,685,119.85
  购建固定资产、无形资产和其他长期资产支付的现金6,685,345.255,910,613.0542,308,678.9124,821,271.08
  投资支付的现金-20,400,00020,400,000-
  支付其他与投资活动有关的现金-000
  投资活动现金流出小计6,685,345.276,310,613.0562,708,678.9124,821,271.08
  投资活动产生的现金流量净额-6,671,845.251,038,525.8-54,223,559.06-23,136,151.23
三、筹资活动产生的现金流量:
  取得借款收到的现金26,000,000329,129,071.2311,129,071.2311,129,071.2
  筹资活动现金流入小计26,000,000329,129,071.2311,129,071.2311,129,071.2
  偿还债务支付的现金105,754,391.02127,114,561.6123,394,561.6113,394,561.6
  分配股利、利润或偿付利息支付的现金4,527,621.04142,772,809.12122,069,631.57117,020,264.24
  其中:子公司支付给少数股东的股利、利润-15,725,447.98--
  支付其他与筹资活动有关的现金17,828,241.0645,163,522.137,068,997.2837,025,528.79
  筹资活动现金流出小计128,110,253.12315,050,892.82282,533,190.45267,440,354.63
  筹资活动产生的现金流量净额-102,110,253.1214,078,178.3828,595,880.7543,688,716.57
四、汇率变动对现金及现金等价物的影响-1,952,594.2710,064.631,615,246.072,042,172.74
五、现金及现金等价物净增加额-122,086,994.2201,606,431.779,375,228.7242,795,317.1
  加:期初现金及现金等价物余额796,173,029.4594,566,597.63594,566,597.63594,566,597.63
  期末现金及现金等价物余额674,086,035.2796,173,029.4603,941,826.35637,361,914.73
补充资料:
  净利润-122,054,932.22-84,377,354.25
  资产减值准备-61,200,398.79-5,643,012.22
  固定资产和投资性房地产折旧-247,327,521.74-127,339,068.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-247,327,521.74-127,339,068.24
  无形资产摊销-48,249,536.41-23,343,618.15
  长期待摊费用摊销-0-0
  处置固定资产、无形资产和其他长期资产的损失--404,023.42-9,235.51
  固定资产报废损失-4,961,158.7-0
  公允价值变动损失-0-0
  财务费用-23,991,334.62-9,817,134.29
  投资损失-798,682.63--2,465,706.88
  递延所得税--21,953,027.34-673,402.57
  其中:递延所得税资产减少--21,661,474.31-1,257,424.27
    递延所得税负债增加--291,553.03--584,021.7
  存货的减少-65,261,950.18--39,288,172.97
  经营性应收项目的减少--276,785,803.7--234,385,286.1
  经营性应付项目的增加--138,478,763.29-44,560,417.86
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  现金的期末余额-796,173,029.4-637,361,914.73
  减:现金的期初余额-594,566,597.63-594,566,597.63
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额-201,606,431.77-42,795,317.1
公告日期2026-04-252026-04-252025-10-292025-08-23
审计意见(境内)标准无保留意见
TOP↑